Mario Milani

Author PubWeight™ 38.72‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the 'cutaneous variant'. Br J Haematol 2004 2.90
2 Prognostic scoring system for primary CNS lymphomas: the International Extranodal Lymphoma Study Group experience. J Clin Oncol 2003 2.44
3 Structure and functionality in flavivirus NS-proteins: perspectives for drug design. Antiviral Res 2009 1.87
4 Crystal structure of a novel conformational state of the flavivirus NS3 protein: implications for polyprotein processing and viral replication. J Virol 2009 1.29
5 Recognition of RNA cap in the Wesselsbron virus NS5 methyltransferase domain: implications for RNA-capping mechanisms in Flavivirus. J Mol Biol 2008 1.25
6 Crystal structure and activity of Kunjin virus NS3 helicase; protease and helicase domain assembly in the full length NS3 protein. J Mol Biol 2007 1.17
7 Structural bases for substrate recognition and activity in Meaban virus nucleoside-2'-O-methyltransferase. Protein Sci 2007 1.13
8 Ligand-induced dynamical regulation of NO conversion in Mycobacterium tuberculosis truncated hemoglobin-N. Proteins 2006 1.06
9 Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug. J Antimicrob Chemother 2012 1.00
10 Mycobacterial truncated hemoglobins: from genes to functions. Gene 2007 0.99
11 Primary pleural epithelioid angiosarcoma. A case report and review of the literature. Pathol Res Pract 2010 0.99
12 Designing Smac-mimetics as antagonists of XIAP, cIAP1, and cIAP2. Biochem Biophys Res Commun 2008 0.96
13 Structure-based inhibition of Norovirus RNA-dependent RNA polymerases. J Mol Biol 2012 0.91
14 Dimeric Smac mimetics/IAP inhibitors as in vivo-active pro-apoptotic agents. Part II: Structural and biological characterization. Bioorg Med Chem 2012 0.90
15 Ligand interactions in the distal heme pocket of Mycobacterium tuberculosis truncated hemoglobin N: roles of TyrB10 and GlnE11 residues. Biochemistry 2006 0.90
16 Rational design, synthesis and characterization of potent, non-peptidic Smac mimics/XIAP inhibitors as proapoptotic agents for cancer therapy. Bioorg Med Chem 2009 0.89
17 Is renalase a novel player in catecholaminergic signaling? The mystery of the catalytic activity of an intriguing new flavoenzyme. Curr Pharm Des 2013 0.85
18 Recognition of Smac-mimetic compounds by the BIR domain of cIAP1. Protein Sci 2010 0.85
19 Targeting the X-linked inhibitor of apoptosis protein through 4-substituted azabicyclo[5.3.0]alkane smac mimetics. Structure, activity, and recognition principles. J Mol Biol 2008 0.84
20 Protein fold and structure in the truncated (2/2) globin family. Gene 2007 0.84
21 Structural basis for bivalent Smac-mimetics recognition in the IAP protein family. J Mol Biol 2009 0.84
22 Crystal structure of a methyltransferase from a no-known-vector Flavivirus. Biochem Biophys Res Commun 2009 0.84
23 Structural determinants of ligand migration in Mycobacterium tuberculosis truncated hemoglobin O. Proteins 2008 0.83
24 CO sniffing through heme-based sensor proteins. IUBMB Life 2004 0.83
25 The roles of Tyr(CD1) and Trp(G8) in Mycobacterium tuberculosis truncated hemoglobin O in ligand binding and on the heme distal site architecture. Biochemistry 2007 0.83
26 Termination of cardiopulmonary resuscitation in mountain rescue. High Alt Med Biol 2012 0.82
27 Nitric oxide and Mycobacterium leprae pathogenicity. IUBMB Life 2002 0.82
28 Delivery of suramin as an antiviral agent through liposomal systems. ChemMedChem 2014 0.82
29 Viscosity-dependent relaxation significantly modulates the kinetics of CO recombination in the truncated hemoglobin TrHbN from Mycobacterium tuberculosis. J Biol Chem 2004 0.82
30 Protein structure in the truncated (2/2) hemoglobin family. IUBMB Life 2007 0.81
31 Ligand binding to truncated hemoglobin N from Mycobacterium tuberculosis is strongly modulated by the interplay between the distal heme pocket residues and internal water. J Biol Chem 2008 0.81
32 Preliminary crystallographic characterization of an RNA helicase from Kunjin virus. Acta Crystallogr Sect F Struct Biol Cryst Commun 2006 0.81
33 Nitric oxide scavenging by Mycobacterium leprae GlbO involves the formation of the ferric heme-bound peroxynitrite intermediate. Biochem Biophys Res Commun 2005 0.81
34 Peroxynitrite scavenging by ferrous truncated hemoglobin GlbO from Mycobacterium leprae. Biochem Biophys Res Commun 2006 0.80
35 Flaviviral helicase: insights into the mechanism of action of a motor protein. Biochem Biophys Res Commun 2011 0.79
36 The truncated hemoglobin from Mycobacterium leprae. Biochem Biophys Res Commun 2002 0.79
37 Mapping heme-ligand tunnels in group I truncated(2/2) hemoglobins. Methods Enzymol 2008 0.79
38 Structural insight into inhibitor of apoptosis proteins recognition by a potent divalent smac-mimetic. PLoS One 2012 0.79
39 Preliminary characterization of (nucleoside-2'-O-)-methyltransferase crystals from Meaban and Yokose flaviviruses. Acta Crystallogr Sect F Struct Biol Cryst Commun 2006 0.78
40 Managing moderate and severe pain in mountain rescue. High Alt Med Biol 2014 0.75
41 NF023 binding to XIAP-BIR1: searching drugs for regulation of the NF-κB pathway. Proteins 2015 0.75
42 Computational and experimental characterization of NF023, a candidate anticancer compound inhibiting cIAP2/TRAF2 assembly. J Chem Inf Model 2020 0.75
43 Plasmodium falciparum ferredoxin-NADP+ reductase His286 plays a dual role in NADP(H) binding and catalysis. Biochemistry 2009 0.75
44 Evidence for self-association of the alternative sigma factor σ54. FEBS J 2013 0.75